Additionally, interleukins IL-4, IL-8 and IL-1RA seem to predict progression from latent to clinical disease, while in individuals with advanced RHD co-regulated expression of IL-6 and TNF-α associate with severe valvular dysfunction, and higher IL-10 and IL-4 levels predicted adverse clinical outcomes [100]. The gene discussed is IL10; the disease is rheumatic heart disease.